Radiation-induced myonecrosis presenting as a subcutaneous mass after combined modality therapy for non-small cell lung cancer.
Velcheti
Vamsidhar
V
Division of Oncology, Alvin J. Siteman Cancer Center Washington University School of Medicine, St. Louis, Missouri, USA.
Gilstrap
Eve
E
Bradley
Jeffrey
J
Govindan
Ramaswamy
R
D000970:Antineoplastic Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001706:Biopsy; D016190:Carboplatin / Q000008:administration & dosage; D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis / Q000188:drug therapy / Q000532:radiotherapy*; D003131:Combined Modality Therapy / Q000009:adverse effects; D003937:Diagnosis, Differential; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000473:pathology* / Q000528:radiation effects; D009336:Necrosis; D017239:Paclitaxel / Q000008:administration & dosage; D011832:Radiation Injuries / Q000473:pathology*; D013909:Thorax; D015899:Tomography, Emission-Computed, Single-Photon; D014057:Tomography, X-Ray Computed